Romina Abyaneh: Key Molecular Mechanisms Influencing Glioma Response to Radiotherapy
Romina Abyaneh, Research Assistant at the Radiation Oncology Research Center at the Tehran University of Medical Sciences, shared a post on LinkedIn about a paper she co-authored with colleagues published in BMC Cancer:
“So excited to share our newly published review in BMC Cancer:
‘Predictive Molecular Biomarkers of Radiosensitivity in Adult Glioma’
We highlighted key molecular mechanisms influencing glioma response to radiotherapy, with insights from both preclinical and clinical studies, paving the way toward biomarker-guided, personalized treatment strategies.
Many thanks to Dr. Reza Ghalehtaki, Dr. Alba Fiorentino, and Dr. Paola Anna Jablonska for their insightful guidance and generous support throughout this project.
Read the full article.”
Alba Fiorentino, Chief of Diagnostic and Therapeutic Department and Chief of Radiation Oncology at Ecclesiastical Institution Regional General Hospital ‘F. MIULLI’, shared this post, adding:
“Recent studies have identified key biomarkers that influence tumor cell survival, prognosis, and therapeutic response in high-grade gliomas, especially GBM. These factors are implicated in diverse pathways, including immune-related mechanisms, hypoxia, cell cycle, apoptosis, and stress response. This article explores the complex paradigm of predictive molecular biomarkers for glioma radiosensitivity and offers a comprehensive review of recent advancements in this field.
I would like to express my gratitude to Romina Abyaneh and Prof. Reza Ghalehtaki for this wonderful collaboration!”
Title: Predictive molecular biomarkers of radiosensitivity in adult glioma: a narrative review
Authors: Romina Abyaneh, Sanaz Bordbar, Soroush Moradi, Sina Molavizade, Shiva Fallahianshafiei, Paola Anna Jablonska, Alba Fiorentino, Reza Ghalehtaki
You can read the Full Article in BMC Cancer.
You can find more posts featuring Romina Abyaneh in OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023